Substance Use, Pregnancy, and HIV/AIDS: Treatment Programs for Pregnant Women
This living document identifies existing substance use treatment programs and services available to pregnant women and pregnant women living with HIV/AIDS in North America, with a particular focus on Saskatchewan. The information provided through the current environmental scan is useful both for pregnant women who use substances who are seeking services, and for healthcare professionals, who can use this information to assist women in accessing services that are appropriate to their needs. Ideally, this would be done as part of a multidisciplinary team, where the referring professional continues to be involved in the care of the woman. It is hoped that the information provided will increase awareness of the existing substance use treatment centres and programs for pregnant women, with the goal of potentially increasing referrals to and use of these programs.
HIV: Healthy Pregnancies and Healthy Babies
This booklet is designed for women living with HIV who are planning a pregnancy or are already pregnant. Topics include basic HIV and HIV treatment information, how to stay healthy before and during pregnancy, unique issues that may face women living with HIV, and where to go for more information and support. The booklet is an update to the previous HIV and pregnancy-related pamphlets provided by the Saskatchewan Prevention Institute.SKU: 7-005
A Review of Nutritional Recommendations for Pregnant Women Living with HIV
Ensuring proper nutrition is a critical component of living with HIV as it is with being pregnant. The two conditions combined mean that pregnant women living with HIV are especially vulnerable to nutrient deficiencies and these women must monitor their nutritional status accordingly. The review provides general recommendations to address these issues.SKU: 7-510
The Impact of Substance Use on Mother-to-child Transmission of HIV
This literature review aimed to assess the impact of substance use on mother-to-child transmission (MTCT) of HIV. Such a review was deemed necessary due to Saskatchewan’s unique HIV profile. Specifically, new cases of HIV in Saskatchewan are: (a) the highest in Canada; (b) most often associated with injection drug use (IDU); and (c) increasing rapidly in women of childbearing age (ages 15 to 39). The primary questions addressed in the report include: Why do substance use services need to be focused on to avoid MTCT of HIV? How does having a substance use issue influence high risk behaviours that can lead to HIV infection? How does having a substance use issue affect virus progression and impact the health of pregnant women living with HIV?SKU: 7-508